UNSPSC 51202305: Penicillamine hydrochloride

This classification denotes an angiogenesis activator inhibitor with the molecular formula C5H11NO2S.ClH, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 5N9JK529ZJ, chemically known as valine, 3-mercapto-, hydrochloride, d- but more generally known as penicillamine hydrochloride, which bears US NIH Compound Identifier 92173. European Medicines Agency schedules Penicillamine hydrochloride in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB03676MIG.

Most nations, for tariff and trade purposes, schedule penicillamine hydrochloride under HS 29309016 and SITC 51549. As of Q4 2014, PENICILLAMINE HYDROCHLORIDE remains US FDA's Preferred Term for this commodity. SMILES: CC(C)([C@H](C(=O)O)N)S.CL.

UNSPSC 51202305 Penicillamine hydrochloride is a Commodity code that nominally covers a single pharmaceutical active ingredient, but recent state and local solicitations tagged to this code show minimal actual activity in penicillamine procurement and instead reflect broader pharmaceutical supply acquisition—naloxone, generic multi-source drugs, and OTC products. State and local governments are using this code tag to procure emergency-response medications, pharmaceuticals through cooperative purchasing alliances, and pharmacy benefit program support across health departments, county health systems, and multi-state purchasing consortiums. The work ranges from direct purchase of finished goods (naloxone kits and drug deactivation systems) to wholesale supply agreements for generic drugs and OTC items distributed through authorized pharmacy wholesalers under fixed or negotiated pricing models.

Recent activity appears concentrated in the South and Upper Midwest, with solicitations from Seminole County, Florida; the Texas Health and Human Services Commission; and the Minnesota Multistate Cooperative Purchasing Alliance (MMCAP), which serves multiple states including Oregon. Seminole County issued IFB 60459723LAS in June 2026 seeking 1,900 units of naloxone and 800 safe drug deactivation systems annually with quarterly deliveries to Sanford, Florida, due July 26, 2023. The Texas HHS Commission posted RFI HHS0017013 on April 3, 2026 to gather vendor capabilities for a Therapeutic Pharmacy Initiative Direct-to-Manufacturer Prescriptions program that would bypass traditional pharmacy benefit managers and wholesalers. MMCAP released an RFP (S1070000015802) in January 2026 for generic multi-source pharmaceuticals and OTC products, with proposals due March 26, 2026 and contract awards effective July 1, 2026; vendors must maintain relationships with AmerisourceBergen Drug Corporation, Cardinal Health, or Morris & Dickson Co. and submit pricing in flat, net, or WAC-minus formats. None of these recent opportunities directly solicit penicillamine hydrochloride by name, suggesting the code assignment reflects either systematic miscoding or use of the code as a catch-all for pharmaceutical procurement activity outside narrowly defined commodity categories.